
Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.

Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.
About Us Deep Genomics is at the forefront of integrating artificial intelligence and complex biology to transform drug discovery. Our proprietary machine learning platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, genetics, chemistry and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how medicines are created.
The Principal Research Associate/ Research Scientist will join our in vivo Pharmacology team within the Platform Biology group and will be a key player in driving our cutting-edge AI RNA therapeutics discovery platform. In this role, you will be responsible for helping lead in vivo therapeutic efficacy testing efforts of novel RNA therapeutics in various animal models. You will also support target validation, therapeutic lead optimization and drug profiling through the implementation and execution of novel molecular assays to advance our internal therapeutics portfolio. The ideal candidate will have a strong molecular biology background with expertise in processing tissue samples as well as experience with rodent models. Relevant knowledge of RNA modalities such as ADAR, ASO, mRNA and/or siRNAs is also highly beneficial. The successful candidate should demonstrate initiative and be able to thrive in a dynamic work environment with cross-functional teams working together to achieve company goals. Title is commensurate with prior experience.
This position is onsite at our Cambridge, MA site.
Key Responsibilities
Basic Qualifications
Preferred Qualifications
What We Offer
Deep Genomics welcomes and encourages applications from people with disabilities. Accommodations are available on request for candidates taking part in all aspects of the selection process.
Deep Genomics thanks all applicants, however only those selected for an interview will be contacted.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.